events
16 September 2019
Da Volterra attending CICON 2019 in Paris on Sept. 25-28!
CICON 2019 is the 5th International Cancer Immunotherapy conference, the reference meeting for scientists, clinicians, regulators, drug developers, and patient…
The US Patent and Trademark Office has recently granted a new patent for Da Volterra in the USA. The patent received number 9,968,562 and includes claims covering composition of matter and methods of use for DAV132, our innovative product designed to protect the intestinal microbiota in patients taking antibiotics.
This patent reinforces our intellectual property portfolio and comes as a complement to the already 100+ patents protecting DAV132 worldwide.
